Enabling long-lasting cell therapy for diabetes without injection
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Medicine by Design-funded foundational technology grows into biotech success story: Notch Therapeutics closes an $85 million Series A financing
Medicine by Design-funded research program that aims to generate next-generation immunomodulation therapies has seeded a Canadian biotechnology success story with the closing of an $85-million (U.S.) Series A financing.
Meet our New Investigator: Omar F. Khan
Nanotechnology expert brings rich experience in academia and industry to the Institute of Biomedical Engineering.
Medicine by Design invests $1.2 million in new ideas to advance regenerative medicine research and translation
Nine funded projects span synthetic biology, computational modelling, immunoengineering and organoids